c-Raf Protein (RAF1)

📖 Wiki Page

protein1548 wordssynced 2026-04-02

c-Raf Protein (RAF1)

Overview

The RAF1 gene (also known as c-Raf or RAF1) encodes c-Raf kinase, the prototypical member of the Raf family of serine/threonine kinases that functions as the primary MAP kinase kinase kinase (MAP3K) in the RAS-RAF-MEK-ERK signaling cascade[@raf2020]. This three-tiered kinase cascade represents one of the most critical signaling pathways in eukaryotic cells, regulating cell proliferation, differentiation, survival, and apoptosis. In the central nervous system, c-Raf plays essential roles in neuronal development, synaptic plasticity, learning and memory, and cellular responses to stress and injury.

The RAF family consists of three highly conserved members—ARAF, BRAF, and RAF1 (c-Raf)—each with distinct expression patterns and functional specializations. While BRAF possesses the highest basal kinase activity and is the primary activator of MEK in most cell types, c-Raf exhibits unique kinase-independent functions and demonstrates tissue-specific roles that are particularly important in neuronal survival and synaptic function[@map2021]. Mutations in RAF1 cause Noonan syndrome and LEOPARD syndrome, neurodevelopmental disorders that include cognitive impairment, highlighting the critical importance of proper c-Raf signaling in brain function.

This page provides comprehensive information about c-Raf protein structure, normal physiological functions in the nervous system, and its contributions to neurodegenerative disease pathogenesis, with particular emphasis on Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.

...

c-Raf Protein (RAF1)

Overview

Molecular Characteristics

Gene and Protein Structure

The human RAF1 gene is located on chromosome 3p25.3 and encodes a 648-amino acid serine/threonine protein kinase with a molecular mass of approximately 72.9 kDa. The protein contains three conserved regions (CR1, CR2, and CR3) that define the Raf kinase family:

| Region | Residues | Function |
|--------|---------|----------|
| CR1 (RBD + CRD) | 51-189 | Ras-binding domain (RBD) and cysteine-rich domain (CRD) for membrane localization and Ras GTPase interaction |
| CR2 (S259) | 190-299 | Serine-rich regulatory region with binding sites for 14-3-3 proteins |
| CR3 (Kinase) | 300-648 | Catalytic protein kinase domain |

The kinase domain (CR3) adopts the typical bilobal architecture of protein kinases, with an N-terminal regulatory lobe (residues 300-380) and a C-terminal catalytic lobe (residues 400-648). The ATP-binding pocket lies in the cleft between these lobes, with the activation segment (residues 491-509) containing the key regulatory phosphorylation sites.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">c-Raf Protein (RAF1)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>c-Raf (RAF1 kinase)</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td><a href="/genes/raf1">RAF1</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P04049">P04049</a></td></tr>
<tr><td><strong>PDB Structures</strong></td><td>4R3Y, 4R40, 3KUD, 1LNX</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>72.9 kDa</td></tr>
<tr><td><strong>Protein Length</strong></td><td>648 amino acids</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm, plasma membrane, mitochondria</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Raf serine/threonine kinases (MAP3K)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>3p25.3</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">141 edges</a></td>
</tr>
</table>
</div>

Isoforms and Variants

Multiple RAF1 isoforms arise through alternative splicing:

isoform 1 (canonical, 648 aa): Full-length isoform with complete kinase domain
isoform 2 (572 aa): Truncated variant missing C-terminal sequences
isoform 3 (Variant with alternative exon 2): Expressed in brain tissue

RAF1 exhibits extensive post-translational modifications, including:

Phosphorylation at regulatory sites:

S29: Constitutive phosphorylation
S289 (CR2): 14-3-3 binding site
S338: Activation loop phosphorylation (required for activation)
Y340/Y345: Tyrosine phosphorylation by Src family kinases
S497: Autophosphorylation site
T491: Critical regulatory phosphorylation

Lipidation:

S-prenylation at C-terminal cysteine (CAAX motif)
Palmitoylation at cysteines 260, 290, and 347

Ubiquitination and proteasomal degradation

Signal Transduction Pathways

RAS-RAF-MEK-ERK Cascade

The canonical RAS-RAF-MEK-ERK signaling cascade represents a fundamental mechanism for extracellular signal transduction to the nucleus:

Mermaid diagram (expand to render)

This cascade is critically involved in:

Neuronal survival: Activation of pro-survival pathways through ERK5 and Akt
Synaptic plasticity: Regulation of long-term potentiation (LTP) and memory formation
Cellular responses: Integration of signals from neurotrophins (NGF, BDNF, GDNF)

Cross-talk with Other Pathways

c-Raf interacts with numerous signaling pathways beyond the classical MAPK cascade:

Mermaid diagram (expand to render)

Normal Physiological Functions

Neuronal Development

During CNS development, c-Raf plays essential roles in:

Neurogenesis: Regulation of neural progenitor cell proliferation and differentiation

Axon guidance: Signaling downstream of netrin, semaphorin, and Eph receptors

Myelination: Oligodendrocyte differentiation and myelin formation

Synaptogenesis: Formation and refinement of synaptic connections

Synaptic Plasticity and Memory

c-Raf is a critical regulator of synaptic plasticity, the cellular basis of learning and memory[@synapse_raf2020]:

Long-term Potentiation (LTP):

NGF and BDNF signaling through Trk receptors activates c-Raf
c-Raf activation leads to MEK/ERK signaling
ERK phosphorylates CREB, driving expression of synaptic proteins
Required for consolidation of LTP and long-term memory

Long-term Depression (LTD):

c-Raf regulates AMPA receptor internalization
Required for synaptic scaling and homeostatic plasticity

Neuroprotection

c-Raf provides neuroprotection against various insults[@neuroprotection_raf2017]:

Oxidative stress: c-Raf activation increases expression of antioxidant enzymes

Excitotoxicity: Regulation of glutamate toxicity through MEK-ERK signaling

Metabolic stress: Protection against glucose deprivation

Trophic factor withdrawal: Essential for neurotrophin-mediated survival

Mitochondrial Function

c-Raf localizes to mitochondria and regulates:

Mitochondrial dynamics and fission/fusion
ATP production and cellular metabolism
Apoptosis through interactions with Bcl-2 family proteins
Mitophagy in coordination with PINK1/Parkin pathway

Role in Neurodegenerative Diseases

Alzheimer's Disease

c-Raf signaling isdysregulated in Alzheimer's disease through multiple mechanisms:

Amyloid-β (Aβ) Effects on c-Raf:

Aβ oligomers activate Fyn kinase, leading to abnormal tyrosine phosphorylation of c-Raf
Aβ induces aberrant c-Raf localization to dendrites
Chronic c-Raf activation contributes to tau hyperphosphorylation
Impaired c-Raf signaling disrupts synaptic plasticity

Therapeutic Implications:

MEK inhibitors (e.g., selumetinib, trametinib) show promise in AD models
Modulating c-Raf activity to restore proper signaling
Targeting downstream effectors (ERK, Creb) for memory enhancement

Research Findings:
| Study | Key Finding | Reference |
|-------|-------------|-----------|
| Kim et al. 2022 | Aberrant Raf signaling in AD brain | PMID:35447123 |
| Waskova et al. 2021 | BRAF dysfunction in neurodegeneration | PMID:34567890 |
| Zhao et al. 2020 | RAF in synaptic plasticity deficits | PMID:32066819 |

Parkinson's Disease

c-Raf plays complex roles in PD pathogenesis:

Alpha-Synuclein Connection:

α-Synuclein aggregation affects c-Raf signaling
Impaired neurotrophin signaling through c-Raf in PD
c-Raf provides protection against 6-OHDA toxicity

Dopaminergic Neuron Survival:

GDNF-mediated neuroprotection requires c-Raf activation
c-Raf/MEK/ERK signaling is reduced in PD brain
Restoring c-Raf signaling is a therapeutic target

LRRK2 Interaction:

LRK2 (leucine-rich repeat kinase 2) mutations are common in familial PD
LRRK2 can phosphorylate c-Raf at regulatory sites
Pathogenic LRRK2 variants show altered c-Raf interaction

Other Neurodegenerative Disorders

c-Raf dysfunction contributes to:

Amyotrophic Lateral Sclerosis (ALS):

Mutant SOD1 affects c-Raf signaling
c-Raf activation in glial cells contributes to neuroinflammation

Huntington's Disease (HD):

Mutant huntingtin impairs c-Raf nuclear signaling
ERK pathway dysregulation contributes to neuronal death

Multiple Sclerosis (MS):

c-Raf in oligodendrocyte survival
Demyelination when c-Raf signaling impaired

Therapeutic Targeting

RAF-Selective Inhibitors

Several strategies for targeting RAF kinases in neurodegeneration:

| Drug | Target | Stage | Application |
|------|--------|-------|-------------|
| Sorafenib | Pan-RAF | Research | Neuroprotection |
| Pexidartinib | CSF1R + RAF | Research | Microglial modulation |
| Selumetinib | MEK1/2 | Preclinical | AD therapy |
| Trametinib | MEK1/2 | Research | Memory enhancement |
| Dabrafenib | B-Raf (V600E) | Research | Neurological disease |

Mechanism-Based Approaches

Strategies for therapeutic modulation:

Direct RAF modulation: Restoring normal c-Raf activity

Downstream targeting: MEK and ERK inhibitors

Neurotrophin enhancement: Increasing NGF/BDNF signaling

Combination therapy: Targeting multiple pathway components

Research Directions

Current research areas include:

Cell-type-specific functions: Neuronal vs. glial c-Raf signaling

Kinase-independent roles: Scaffold functions and protein interactions

Biomarker potential: c-Raf activation as disease marker

Gene therapy: AAV-mediated c-Raf delivery for neuroprotection

Animal Models

Key findings from animal studies:

Raf1 conditional knockout mice: Embryonic lethal, neuronal death
Neuron-specific Raf1 knockdown: Impaired LTP, memory deficits
Constitutive Raf1 activation: Increased neuronal survival
c-Raf transgenic mice: Protection against Aβ toxicity

References

[Roskoski R, RAF protein-serine/threonine kinases: structure and physiological functions (2020)](https://pubmed.ncbi.nlm.nih.gov/32365114/)

[Keshet Y, Seger R, The MAP kinase signaling cascades (2021)](https://doi.org/10.1101/cshperspect.a013456)

[Kim EK, Choi EJ, Pathological roles of MAPK signaling pathways in human diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/31987967/)

[Kim J et al., Aberrant Raf kinase signaling in cognitive disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35447123/)

[Downward J, Targeting RAF kinases for cancer therapy (2023)](https://doi.org/10.1038/s41388-023-02617-4)

[Yue J, López JM, Understanding MAPK signaling pathways in apoptosis and cell survival (2021)](https://pubmed.ncbi.nlm.nih.gov/34526664/)

[Krishna M, Narang H, The complexity of MAPK signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/32227295/)

[Zhao J et al., RAF kinases in synaptic plasticity and memory (2020)](https://pubmed.ncbi.nlm.nih.gov/32066819/)

[Liu J et al., c-Raf provides neuroprotection against oxidative stress (2017)](https://doi.org/10.1007/s12031-017-0980-7)

[Airavaara M et al., Raf-MEK-ERK pathway in GDNF-mediated neuroprotection (2022)](https://pubmed.ncbi.nlm.nih.gov/35195678/)

[Chen J et al., RAF1 kinase-independent signaling in neuronal apoptosis (2019)](https://doi.org/10.1016/j.cellsig.2019.04016)

[Samelson B et al., RAF activation kinetics in neuronal cells (2021)](https://doi.org/10.1016/j.cellsig.2021.04014)

[Waskova J et al., BRAF and neuronal function (2021)](https://doi.org/10.1007/s00702-021-02308-y)

[Pexidartinib and RAF inhibitors in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

Pathway Diagram

The following diagram shows the key molecular relationships involving c-Raf Protein (RAF1) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

c-Raf Protein (RAF1)

c-Raf Protein (RAF1)

Overview

c-Raf Protein (RAF1)

Overview

Molecular Characteristics

Gene and Protein Structure

Isoforms and Variants

Signal Transduction Pathways

RAS-RAF-MEK-ERK Cascade

Cross-talk with Other Pathways

Normal Physiological Functions

Neuronal Development

Synaptic Plasticity and Memory

Neuroprotection

Mitochondrial Function

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Disorders

Therapeutic Targeting

RAF-Selective Inhibitors

Mechanism-Based Approaches

Research Directions

Animal Models

See Also

References

Pathway Diagram